Trials / Unknown
UnknownNCT02903212
Tolerance and Effectiveness of Cell Therapy by Autologous Apoptotic Cells in the Treatment of Rheumatoid Arthritis
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 22 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to determine the tolerance of apoptotic autologous cells injection in subjects with active rheumatoid arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous apoptotic cells injection | cells injection |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2024-06-01
- Completion
- 2024-12-01
- First posted
- 2016-09-16
- Last updated
- 2022-04-06
Source: ClinicalTrials.gov record NCT02903212. Inclusion in this directory is not an endorsement.